Age-dependent abnormalities of hematopoietic stem cells in (NZW x BXSB)F1 mice

Stem Cells

Volumn 17, Issue 6, 1999, Pages 357-365

  Sugihara, Akira ^a   Adachi, Yasushi ^a   Inaba, Muneo ^a   Hisha, Hiroko ^a   Sugiura, Kikuya ^a   Miyashima, Shigeo ^a   Amoh, Yasuo ^a   Taketani, Shigeru ^a   Oyaizu, Haruki ^a   Ikebukuro, Kazuya ^a   Kawamura, Masayo ^a   Genba, Hisae ^a   Horio, Takeshi ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Autoimmune diseases; BMT; Cytokines; Leukocytosis; Stem cells; W BF1 mice

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; COLONY FORMING UNIT C; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; COLONY FORMING UNIT S; HEMATOPOIESIS; IMMUNOPATHOGENESIS; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; ONSET AGE; SURVIVAL RATE; THROMBOCYTOPENIA;

EID: 0032757207     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.170357     Document Type: Article

References (30)

1. Ikehara S, Yasumizu R, Inaba M et al. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1989;86:3306-3310.
2. Ikehara S, Inaba M, Ishida S et al. Rationale for transplantation of both allogeneic bone marrow and stromal cells in the treatment of autoimmune diseases. In: Champlin RE, Gale RP, eds. New Strategies in Bone Marrow Transplantation. UCLA Symposia on Molecular and Cellular Biology, New Series. New York, Chichester, Brisbane, Toronto, Singapore: Wiley-Liss, 1991;251-257.
3. Ishida T, Inaba M, Hisha H et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. J Immunol 1994;152:3119-3127.
4. Ikehara S, Ohtsuki H, Good RA et al. Prevention of type I diabetes in non obese diabetic mice by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1985;82:7743-7747.
5. Yasumizu R, Sugiura K, Iwai H et al. Treatment of type I diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue. Proc Natl Acad Sci USA 1987;84:6555-6557.
6. Soe Than, Ishida H, Inaba M et al. Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice. J Exp Med 1992;176:1233-1238.
7. 1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction. J Exp Med 1981;154:216-221.
8. 1 mouse: a new animal model of idiopathic thrombocytopenic purpura. J Exp Med 1988;167:2017-2022.
9. Adachi Y, Inaba M, Amoh Y et al. Effect of bone marrow transplantation on antiphospholipid antibody syndrome in murine lupus mice. Immunobiology 1995;192:218-230.
10. 1 mice. Blood 1993;82:837-844.
11. Hang LM, Stephens-Larson P, Henry JP et al. The role of hypertension in the vascular disease and myocardial infarctions associated with murine systemic lupus erythematosus. Arthritis Rheum 1983;26:1340-1345.
12. 1 mice. Autoimmunity 1993;15:99-105.
13. 1 mice. Immunobiology 1993;188:340-354.
14. 1 mice, a model of antiphospholipid syndrome. J Immunol 1992;149:1063-1068.
15. DesJardin LE, Butfiloski EJ, Sobel ES et al. Hyperproliferation of BXSB B cells is linked to allele. Clin Immunol Immunopathol 1996;81:145-152.
16. 1 mice by haploidentical bone marrow transplantation: possible role for anticardiolipin autoantibodies. Blood 1993;82:3091-3097.
17. Ikehara S, Kawamura M, Takao F et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA 1990;87:8341-8344.
18. Tanaka T, Akira S, Yoshida K et al. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 1995;80:353-361.
19. Moriyama H, Yamamoto T, Takatsuka H et al. Expression of macrophage colony-stimulating factor and its receptor in hepatic granulomas of Kupffer-cell-depleted mice. Am J Pathol 1997;150:2047-2060.
20. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 1961;14:213-222.
21. Nakahata T, Ogawa M. Identification in culture of a class of hemopoietic colony-forming units with extensive capacity to self-renew and generate multipotential hemopoietic colonies. Proc Natl Acad Sci USA 1982;79:3843-3847.
22. Hashimoto F, Sugiura K, Inoue K et al. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo. Blood 1997;89:49-54.
23. Sugiura K, Inaba M, Hisha H et al. Requirement of major histocompatibility complex-compatible microenvironment for spleen colony formation (CFU-S on day 12 but not on day 8). STEM CELLS 1997;15:461-468.
24. Kawamura M, Hisha H, Li Y et al. Distinct quantitative differences between normal and abnormal hemopoietic stem cells in vivo and in vitro. STEM CELLS 1997;15:56-62.
25. Motoyoshi K. Biological activities and clinical application of M-CSF. Int J Hematol 1998;67:109-122.
26. Reeves WH, Lahita RG. Clinical presentation of systemic lupus erythematosus in the adult. In: Lahita RG, ed. Systemic Lupus Erythematosus. New York, NY: Churchill Livingstone, 1992:369-396.
27. Vieten G, Hadam MR, Boer HD et al. Expanded macrophage precursor population in BXSB mice: possible reason for the increasing monocytosis in male mice. Clin Immunol Immunopath 1992;65:212-218.
28. Gabrilove JL, Jakubowski A, Fain K et al. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 1988;82:1454-1461.
29. Lindemann A, Herrmann F, Oster W et al. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 1989;74:2644-2651.
30. Ranaghan L, Drake M, Humphreys MW et al. Leukaemoid monocytosis in M4 AML following chemotherapy and G-CSF. Clin Lab Haematol 1998;20:49-51.